Peptides selectively lethal to malignant and transformed mammalian cells

Details for Australian Patent Application No. 2004321478 (hide)

Owner The Research Foundation of State University of New York

Inventors Pincus, Matthew

Agent Fisher Adams Kelly

Pub. Number AU-A-2004321478

PCT Pub. Number WO2006/006954

Priority PCT/ US2004/000684 13.01.04 US

Filing date 22 December 2004

Wipo publication date 19 January 2006

International Classifications

C07K 7/00 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

10 August 2006 PCT application entered the National Phase

  PCT publication WO2006/006954 Priority application(s): WO2006/006954

4 December 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004321500-Immunoglobulins with potent and broad antiviral activity

2004321469-Context-based encoding and decoding of signals